Related Experiment Videos
CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood
1Department of Child and Adolescent Psychiatry, East Hospital University.
Insights
Autistic children show higher levels of homovanillic acid (HVA), a dopamine metabolite, in spinal fluid. This suggests a potential link between dopamine system overactivity and the development of autism.
Area of Science:
- Neuroscience
- Child Psychiatry
- Biochemistry
Background:
- Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition.
- Monoamine neurotransmitters play crucial roles in brain function.
- Altered monoamine metabolism has been implicated in various neurodevelopmental disorders.
Purpose of the Study:
- To investigate spinal fluid concentrations of monoamine metabolites in children with autism.
- To compare these levels with those in children with other childhood psychoses and neurodevelopmental disorders.
- To explore the potential role of monoamine pathways in autism pathogenesis.
Main Methods:
- Analysis of cerebrospinal fluid (CSF) for homovanillic acid (HVA), and metabolites of serotonin and norepinephrine.
- Comparison of metabolite levels in 25 autistic children, 12 children with other psychoses, and control groups (normal, neurological, and neurodevelopmental disorders).
Main Results:
- Autistic children exhibited significantly elevated absolute and relative levels of HVA, a dopamine metabolite.
- Children with other childhood psychoses also showed increased HVA levels.
- Indications of elevated serotonin and norepinephrine metabolites were observed in the other childhood psychoses group.
Conclusions:
- The findings suggest a hyperfunction of dopaminergic pathways in the brain stem-mesolimbic system in infantile autism.
- Altered monoamine metabolism, particularly involving dopamine, may be a key factor in the pathophysiology of autism.
- Further research into dopaminergic system modulation could offer therapeutic targets for autism.
Abstract:
Spinal fluid concentrations of the three major monoamine metabolites were examined in 25 infantile autistic children and 12 children with other childhood psychoses, and were contrasted with results obtained in normal children and in groups of children with neurological and neurodevelopmental disorders. Autistic children showed absolute and relative increases of the dopamine metabolite homovanillic acid. The group with other childhood psychoses also showed an increase in HVA level; in this group there were also indications of high levels of serotonin and norepinephrine metabolites. The results are discussed in the context of a pathogenetic model for autism involving hyperfunction of dopaminergic nerve fibres in the brain stem-mesolimbic system.